E2F3—A Novel Repressor of the ARF/p53 Pathway
- 1 June 2004
- journal article
- editorial
- Published by Elsevier in Developmental Cell
- Vol. 6 (6) , 742-743
- https://doi.org/10.1016/j.devcel.2004.05.012
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kineticsGenes & Development, 2004
- Tumor suppression by Ink4a–Arf: progress and puzzlesCurrent Opinion in Genetics & Development, 2003
- E2F1 pathways to apoptosisFEBS Letters, 2002
- The RB and p53 pathways in cancerCancer Cell, 2002
- The genetics of the E2F family of transcription factors: shared functions and unique rolesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2002
- The INK4a/ARF network in tumour suppressionNature Reviews Molecular Cell Biology, 2001
- Identification of a Novel E2F3 Product Suggests a Mechanism for Determining Specificity of Repression by Rb ProteinsMolecular and Cellular Biology, 2000
- Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repressionGenes & Development, 2000
- The p16INK4a/CDKN2A tumor suppressor and its relativesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1998
- p14ARF links the tumour suppressors RB and p53Nature, 1998